Previous 10 | Next 10 |
Paves Way for Disease Elimination by Radio Frequency Waves JACKSON CENTER, PA / ACCESSWIRE / March 30, 2021 / Halberd Corporation (OTC PINK:HALB) has successfully conjugated (joined) metallic nanoparticles with its patent-pending SARS-CoV-2 antibody, while still maintaining the antibo...
JACKSON CENTER, PA / ACCESSWIRE / March 23, 2021 / Halberd Corporation (OTC PINK:HALB) has compiled a number of third party published articles from various medical publications which support the selection of the various nutraceuticals in Halberd's VITA-SHIELD-MAX TM Immune Booster. Willi...
JACKSON CENTER, PA / ACCESSWIRE / March 18, 2021 / Halberd Corporation (OTC PINK:HALB) filed an International Patent Cooperation Treaty (PCT) application for coverage of the invention titled, " Method for Treating and Curing Covid-19 Infection. " The Patent Cooperation Treaty has over 150 ...
JACKSON CENTER, PA / ACCESSWIRE / March 16, 2021 / Halberd Corporation (OTC PINK:HALB) has contracted with a major nutraceutical manufacturer to produce its initial production lot of Halberd's VITA-SHIELD-MAX TM Immune Booster. Halberd's scientists designed this proprietary combination of...
JACKSON CENTER, PA / ACCESSWIRE / March 11, 2021 / Halberd Corporation (OTC PINK:HALB) has filed for trademark protection for the name VITA-SHIELD-MAX TM for its proprietary blend of over-the-counter nutraceuticals designed to boost the body's immunity and generally enhance health. Willi...
JACKSON CENTER, PA / ACCESSWIRE / March 9, 2021 / Halberd Corporation's (OTC PINK:HALB) Chairman, President & CEO, William A. Hartman, was interviewed recently on The Stock Day Podcast , hosted by Everett Jolly. In the interview, Mr. Hartman reviewed the company's progress in developi...
Phoenix, Arizona--(Newsfile Corp. - March 9, 2021) - The Stock Day Podcast welcomed Halberd Corporation (OTC Pink: HALB) ("the Company"), a company that holds the exclusive rights to the patented extracorporeal treatment technology and the provisional patent applications associated with COVID-...
Westlake, Louisiana--(Newsfile Corp. - March 8, 2021) - Epidemiologic Solutions Corporation (ESC), a public charity qualified by the Internal Revenue Service pursuant to Section 501(c)(3) commits not less than $2,000,000 of funding to Halberd Corporation (OTC Pink: HALB) research endeavors. ...
HOLLYWOOD, CA / ACCESSWIRE / March 5, 2021 / GPOs, Covid antibodies, self-driving cars, gender benders; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes it happen, ( http://www.moneytv.net ), featuring ...
JACKSON CENTER, PA / ACCESSWIRE / March 2, 2021 / Halberd Corp. (OTC PINK:HALB) has recently produced a proprietary monoclonal antibody that has at least 20 times greater neutralizing affinity than their original antibody against the SARS-COV-2 Spike protein. Dr. Reyes, Halberd's Chief T...
News, Short Squeeze, Breakout and More Instantly...
Walt Disney once said, "All our dreams can come true if we have the courage to pursue them". JACKSON CENTER, PA / ACCESSWIRE / May 22, 2024 / Halberd Corporation (OTC PINK:HALB) in cooperation with Athena GTX, Inc is standing at the threshold of some major advancements to treat the issues ...
Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously. JACKSON CENTER, PA / ACCESSWIRE / May 9, 2024 / Halberd Corporation's (OTC PINK:HALB) two active programs for the treatment and mitigation of the negative ...
LDN+ Drug Designed to Combat PTSD and Suicidal Ideation JACKSON CENTER, PA / ACCESSWIRE / April 30, 2024 / Halberd Corporation (OTC PINK:HALB) announced a pre-pilot study of its patented LDN+ drug with military volunteers has now begun with limited participants but is currently expected to...